|
Research Management and Support
|
RMS ES 2017
|
$326,124,631
|
$21,000
|
N/A
|
National Institutes of Health
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-04S1
|
$1,393,520
|
$55,741
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Network Group Operations Center
|
5U10CA180886-04
|
$22,547,116
|
$901,885
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Consolidated Basic Cancer Research Program
|
3P30CA010815-48S1
|
$142,498
|
$2,850
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
Consolidated Basic Cancer Research Program
|
5P30CA010815-48
|
$2,645,581
|
$52,912
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
Childhood Cancer Survivor Study
|
2U24CA055727-23
|
$3,616,741
|
$361,674
|
ARMSTRONG, GREGORY
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Anatomic Pathology Residency Program
|
ZIE BC 011384
|
$1,094,457
|
$21,889
|
Barr, Frederic
|
CCR (NCI)
|
|
Pooling project of NCI and Cross-Canada studies
|
ZIA CP010119-10649
|
$60,369
|
$12,074
|
Beane Freeman, Laura
|
DCEG (NCI)
|
|
Dana-Farber/Harvard Cancer Center
|
3P30CA006516-52S2
|
$60,000
|
$600
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Dana-Farber/Harvard Cancer Center
|
3P30CA006516-52S3
|
$100,000
|
$1,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Follow-up studies from the NHL/LM GWAS
|
ZIA CP010136-10799
|
$134,022
|
$13,402
|
Berndt, Sonja
|
DCEG (NCI)
|
|
Medical Oncology Fellowship Program
|
ZIE BC 010843
|
$4,201,344
|
$210,067
|
Bilusic, Marijo
|
CCR (NCI)
|
|
Radiation Oncology Branch - Radiation Clinic
|
ZID BC 010990
|
$4,983,045
|
$398,644
|
Camphausen, Kevin
|
CCR (NCI)
|
|
CLL Families-Mayo
|
ZIA CP004410-10312
|
$36,253
|
$1,813
|
Caporaso, Neil
|
DCEG (NCI)
|
|
CCR Genomics Core
|
ZIC BC 011623
|
$850,744
|
$85,074
|
Conner, Elizabeth
|
CCR (NCI)
|
|
Dermatology Consultation Service
|
ZID BC 011317
|
$253,127
|
$75,938
|
Cowen, Edward
|
CCR (NCI)
|
|
Host factors, tumor microenvironment and survival in a multiethnic study of Hodgkin lymphoma patients
|
5R01CA206019-02
|
$816,487
|
$816,487
|
COZEN, WENDY
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Basic and Preclinical Animal Models in support of Cancer and HIV-AIDS Research
|
ZIG BC 010856
|
$14,497,944
|
$724,898
|
Custer, Mary
|
CCR (NCI)
|
|
Children's Oncology Group Statistics and Data Center
|
5U10CA180899-04
|
$7,008,867
|
$700,887
|
DEVIDAS, MEENAKSHI
|
UNIVERSITY OF FLORIDA
|
|
Optimal Antiretroviral Therapy During Bone Marrow Transplant in HIV-1 Infection
|
5K23CA177321-04
|
$161,608
|
$64,643
|
DURAND, CHRISTINE
|
JOHNS HOPKINS UNIVERSITY
|
|
HIV and Cancer
|
ZIA CP010150-10071
|
$90,450
|
$13,567
|
Engels, Eric
|
DCEG (NCI)
|
|
Registry linkage projects [including Scandinavia, SEER Medicare, other]
|
ZIA CP010150-10359
|
$87,105
|
$17,421
|
Engels, Eric
|
DCEG (NCI)
|
|
Cancer Risk in Solid Organ Transplant Recipients
|
ZIA CP010150-10362
|
$143,962
|
$7,198
|
Engels, Eric
|
DCEG (NCI)
|
|
Pharmacokinetic and Pharmacodynamic Modeling of Anticancer Agents
|
ZIC BC 010548
|
$492,058
|
$98,412
|
Figg, William
|
CCR (NCI)
|
|
City of Hope Lymphoma SPORE
|
3P50CA107399-10S1
|
$300,000
|
$78,000
|
FORMAN, STEPHEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Understanding T Cell Rapamycin Resistance
|
ZIA BC 011220
|
$272,402
|
$27,240
|
Fowler, Daniel
|
CCR (NCI)
|
|
Natural History Study of the Complications Associated with Allogeneic HCT
|
ZIA BC 011742
|
$269,487
|
$21,559
|
Gea-Banacloche, Juan
|
CCR (NCI)
|
|
Dana-Farber/Harvard Cancer Center
|
2P30CA006516-52
|
$11,592,798
|
$115,928
|
GLIMCHER, LAURIE
|
DANA-FARBER CANCER INST
|
|
Dana-Farber/Harvard Cancer Center
|
3P30CA006516-52S1
|
$112,500
|
$1,125
|
GLIMCHER, LAURIE
|
DANA-FARBER CANCER INST
|
|
Hodgkin's families
|
ZIA CP004410-08167
|
$79,288
|
$75,324
|
Goldin, Lynn
|
DCEG (NCI)
|
|
Familial case-control study of lymphoproliferative malignancies and auto-immune d
|
ZIA CP005803-00355
|
$3,239
|
$648
|
Goldin, Lynn
|
DCEG (NCI)
|
|
Molecularly Targeted Therapy for Lymphoma
|
5K24CA184039-04
|
$172,224
|
$34,445
|
GOPAL, AJAY
|
UNIVERSITY OF WASHINGTON
|
|
ETIB Clinical Research Core
|
ZID BC 010963
|
$2,035,321
|
$203,532
|
Gress, Ronald
|
CCR (NCI)
|
|
Medical Oncology HIV-AIDS Clinical Research
|
ZID BC 011683
|
$200,544
|
$20,054
|
Gulley, James
|
CCR (NCI)
|
|
Immune reconstitution following autologous and allogeneic stem cell transplant
|
ZIC BC 010934
|
$420,830
|
$84,166
|
Hakim, Frances
|
CCR (NCI)
|
|
Preclinical development and clinical monitoring of adoptive immune therapy
|
ZIC BC 011029
|
$420,830
|
$84,166
|
Hakim, Frances
|
CCR (NCI)
|
|
SPORE in Lymphoma
|
2P50CA126752-11
|
$3,097,657
|
$836,367
|
HESLOP, HELEN
|
BAYLOR COLLEGE OF MEDICINE
|
|
Regulation of transcription and tumor suppression by MTG family members
|
5R01CA178030-04
|
$364,000
|
$120,120
|
HIEBERT, SCOTT
|
VANDERBILT UNIVERSITY
|
|
Hematopathology Diagnosis
|
ZIA BC 011070
|
$656,574
|
$196,972
|
Jaffe, Elaine
|
CCR (NCI)
|
|
Lymphoma Disease Discovery and Definition
|
ZIA SC 000550
|
$574,502
|
$57,450
|
Jaffe, Elaine
|
CCR (NCI)
|
|
Hematopathology Fellowship
|
ZIE BC 011241
|
$410,358
|
$102,590
|
Jaffe, Elaine
|
CCR (NCI)
|
|
Biomarkers and Therapeutic Targets in Angiogenesis and Metastasis
|
ZIA BC 011334
|
$474,811
|
$23,741
|
Kaplan, Rosandra
|
CCR (NCI)
|
|
NCI National Clinical Trials Network-Network Lead Academic Participating Sites
|
5U10CA180836-04
|
$634,404
|
$15,860
|
KINDLER, HEDY
|
UNIVERSITY OF CHICAGO
|
|
Development of fully-human anti-CD30 chimeric antigen receptors
|
ZIA BC 011660
|
$67,909
|
$54,327
|
Kochenderfer, James
|
CCR (NCI)
|
|
Sleep Apnea in Survivors of Childhood Cancer Treated with Thoracic Radiation (APNEA
|
1R01CA215405-01A1
|
$657,845
|
$657,845
|
KRULL, KEVIN
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Brain Integrity in Survivors of Childhood Cancer Treated with Thoracic Radiation
|
5R01CA174794-05
|
$605,760
|
$605,760
|
KRULL, KEVIN
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Mechanisms of transcription factor integration at the c-myc promoter
|
ZIA SC 009144
|
$307,515
|
$30,752
|
Levens, David
|
CCR (NCI)
|
|
Characterization of the hematopoietic stem cell lineage
|
ZIA BC 011505
|
$42,694
|
$6,404
|
Lewandoski, Mark
|
CCR (NCI)
|
|
Regulation of EBV Latency by EBNA1
|
5R01CA093606-15
|
$329,956
|
$263,965
|
LIEBERMAN, PAUL
|
WISTAR INSTITUTE
|
|
SEER, Registries, and Special Projects
|
ZIA CP010131-10560
|
$33,448
|
$3,345
|
Linet, Martha
|
DCEG (NCI)
|
Total relevant funding to Hodgkins disease for this search: $13,018,548
|